Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
PANAMA CITY, Fla. (WJHG/WECP) - Last week, we told you how cancer clinical trials are coming to bay county. Now, we’re taking ...
Study in a Sentence: Cedars-Sinai researchers are developing KronosRx, an artificial intelligence-powered platform that uses human-derived organoids and deep-learning models to forecast adverse drug ...
Revolution Medicines faces high volatility after failed Merck takeover talks, with RVMD shares dropping 18% but still up 115% ...
The first good manufacturing practices facility located on a university campus in the United States opened this fall at the ...
Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to ...
The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, ...
A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though ...
Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that ...
From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug. In 2023, the drug ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Erectile dysfunction (ED), a common and highly treatable condition, affects millions of men, many starting to have symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results